<DOC>
	<DOC>NCT02615418</DOC>
	<brief_summary>This trial is designed to preliminary evaluate the efficacy and safety of NIBS system for treatment of chronic low back pain (CLBP) (over 6 months). The trial is of a double blind sham controlled partial crossover design and will involve 2 weekly treatments and evaluations for 6 weeks, with 6 weeks follow-up. The goal of the study is to 1. Asses the CLBP change immediate and long term effect for the trial duration and follow-up. 2. Asses quality of life improvement as measure by sleep quality and questioners. 3. Asses long term neuronal changes or lack thereof in treated and untreated subjects.</brief_summary>
	<brief_title>Non Invasive Brain Stimulation Treatment for CLBP</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<criteria>Age 18 to 80 CLBP as defined by the European guidelines. low back pain first week average NPRS&gt;4. 1. Acute low back pain (duration of less than 6 months) first week average NPRS&gt; 4 2. Neurological illness causing structural brain damage (e.g. Stroke, TIA) 3. Psychiatric disease other than mood disorders 4. Current chronic use of medications with proepileptic properties 5. Known alcohol dependency 6. Use of alcohol within the previous 24 hours 7. History of loss of consciousness 8. Epilepsy or epilepsy in a first degree relative 9. Medical implants 10. Pregnancy 11. Illicit drug use or within the previous month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>